Product Recalls in New Mexico

Product recalls affecting New Mexico — including food, drugs, consumer products, medical devices, and vehicles distributed to New Mexico. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 1,839 recalls have been distributed to New Mexico in the last 12 months.

48,595 total recalls
1,839 in last 12 months

Showing 2604126060 of 48,595 recalls

DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Ketamine HCl USP for prescription compounding Recalled by American...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Methylcobalamin (Vitamin B12) for prescription compounding Recalled by...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Stanozolol USP for prescription compounding Recalled by American...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Cyanocobalamin USP (Vitamin B12) for prescription compounding Recalled by...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Clonidine HCl USP for prescription compounding Recalled by American...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Desoximetasone USP (Micronized) for prescription compounding Recalled by...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Pentoxifylline USP for prescription compounding Recalled by American...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· Apace KY LLC

Recalled Item: Acyclovir Tablets Recalled by Apace KY LLC Due to Presence of Foreign...

The Issue: Presence of Foreign Tablet/Capsule; cartons labeled to contain Acyclovir...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Medroxyprogesterone Acetate USP (Micronized) for prescription compounding...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Levothyroxine Sodium USP for prescription compounding Recalled by American...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Nifedipine USP for prescription compounding Recalled by American...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Calcipotriene BP (Monohydrate) for prescription compounding Recalled by...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Testosterone Cypionate USP (Micronized) for prescription compounding...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Baclofen USP (Micronized) for prescription compounding Recalled by American...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Cyclobenzaprine HCl USP for prescription compounding Recalled by American...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Tadalafil USP (Monohydrate) for prescription compounding Recalled by...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Gabapentin USP for prescription compounding Recalled by American...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Estradiol USP (Micronized) (Yam) for prescription compounding Recalled by...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Duloxetine HCl USP for prescription compounding Recalled by American...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Sildenafil Citrate USP for prescription compounding Recalled by American...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund